22 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS AlterationSolid Tumor (Phase I)RecruitingPhase 12026-09-04NCT07718165
A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy ParticipantsHealthy ParticipantsRecruitingPhase 12026-07-27NCT07700953
A Phase 2 Study of ABSK043 Combined With OsimertinibNon-Small Cell Lung Cancer With EGFR-mutated and PD-L1 PositiveNot yet recruitingPhase 22026-07-17NCT07710612
A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular CarcinomaDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmRecruitingPhase 22026-07-15NCT07010497
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and GlecirasibNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-06-17NCT07164170
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse typeActive, not recruitingPhase 32026-05-04NCT05804045
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid TumorAdvanced Liver CancerRecruitingPhase 12026-04-07NCT04906434
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumorRecruitingPhase 12026-03-19NCT04192344
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )Solid Tumors, AdultRecruitingPhase 1 / Phase 22026-03-11NCT07417189
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC PatientsDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmEnrolling by invitationPhase 22026-02-25NCT05441475
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 OverexpressionDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmRecruitingPhase 22026-01-08NCT07327034
A Study in Children With AchondroplasiaBone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasiaRecruitingNot stated2025-12-24NCT07301463
A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With AchondroplasiaBone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasiaNot yet recruitingPhase 1 / Phase 22025-12-22NCT07297875
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid TumorsSolid Tumors (Phase 1)RecruitingPhase 12025-12-17NCT07288957
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid TumorsSolid TumorActive, not recruitingPhase 12025-10-20NCT05627063
A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy SubjectsHealthy SubjectsActive, not recruitingPhase 12025-04-20NCT06884072
A Mass Balance Study of [14C]ABSK011Healthy SubjectsNot yet recruitingPhase 12025-03-26NCT06896760
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and FirmonertinibNon-Small Cell Lung Cancer With EGFR MutationRecruitingPhase 22024-12-12NCT06668103
A Phase 2 Clinical Study of ABSK061 and ABSK043Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, transitional cell carcinoma, urothelial carcinomaRecruitingPhase 22024-11-19NCT06632262
A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)cGvHDEnrolling by invitationPhase 22024-08-12NCT06186804
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic CancerAdvanced Pancreatic CancerRecruitingPhase 22024-04-11NCT06111274
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 12024-03-18NCT06225804